$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Enterprise License

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021
[Lowest Price Guaranteed: $5,650]

Published by MarketsandMarkets: 09 Jun 2016 | 51130 | In Stock
Related Topics: Healthcare

Introduction

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, end user, and region. The consumables segment is expected to register the highest growth rate in the cell expansion market, by product, during the forecast period. The high growth in this segment is attributed to the increasing investments in cell-based research.

Based on end user, the cell expansion market is segmented into research institutes, biopharmaceutical and biotechnology companies, cell banks, and others. The research institutes segment is expected to account for the largest share of the market in 2016. The increasing prevalence of diseases and the need to develop new therapies will drive the growth of this market.

Geographically, the cell expansion market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for research in the North American countries.

The major factors contributing to the growth of the cell expansion market include increasing government funding for research, high prevalence of chronic diseases, and growing number of GMP-certified production facilities. Furthermore, increasing R&D spending and new product development activities by companies is another major factor driving the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise product portfolios, developments, and strategies adopted by market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output in order to remain successful in the market.

The major players in this market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the cell expansion market. The report analyses the cell expansion market by product, cell type, application, end user, and region

• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the cell expansion market

• Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the cell expansion market

• Market Development: Comprehensive information about emerging markets. This report analyses the market for various cell expansion market products across geographies

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell expansion market

Table of Contents
for Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021

  • TABLE OF CONTENTS

    1 INTRODUCTION 18

    1.1 OBJECTIVES OF THE STUDY 18

    1.2 MARKET DEFINITION 18

    1.2.1 MARKET SEGMENTATION 19

    1.2.2 YEARS CONSIDERED FOR THE STUDY 20

    1.3 CURRENCY 20

    1.4 LIMITATION 20

    1.5 MARKET STAKEHOLDERS 20

    2 RESEARCH METHODOLOGY 21

    2.1 MARKET SIZE ESTIMATION 22

    2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 25

    2.3 MARKET SHARE ESTIMATION 26

    2.3.1 KEY DATA FROM SECONDARY SOURCES 26

    2.3.2 KEY DATA FROM PRIMARY SOURCES 27

    2.3.3 KEY INDUSTRY INSIGHTS 28

    2.4 ASSUMPTIONS FOR THE STUDY 28

    3 EXECUTIVE SUMMARY 29

    3.1 INTRODUCTION 29

    3.2 CURRENT SCENARIO 29

    3.3 FUTURE OUTLOOK 30

    3.4 CONCLUSION 34

    4 PREMIUM INSIGHTS 35

    4.1 CELL EXPANSION MARKET OVERVIEW 35

    4.2 CELL EXPANSION MARKET, BY PRODUCT 36

    4.3 GEOGRAPHIC ANALYSIS: CELL EXPANSION MARKET, BY CELL TYPE 37

    4.4 CELL EXPANSION MARKET, BY APPLICATION 38

    4.5 GEOGRAPHICAL SNAPSHOT OF THE CELL EXPANSION MARKET 39

    4.6 LIFECYCLE ANALYSIS, BY REGION, 2016 40

    5 MARKET OVERVIEW 41

    5.1 INTRODUCTION 42

    5.2 MARKET SEGMENTATION 43

    5.3 MARKET DYNAMICS 44

    5.3.1 DRIVERS 45

    5.3.1.1 Increasing incidence of chronic diseases 45

    5.3.1.2 Rising government investments for cell-based research 46

    5.3.1.3 Increasing initiatives by companies for research and development of cell-based therapies 46

    5.3.1.4 Increasing number of GMP-certified cell therapy production facilities 48

    5.3.2 RESTRAINTS 49

    5.3.2.1 High cost of cell-based research 49

    5.3.2.2 Ethical concerns regarding research on cell biology 49

    5.3.3 OPPORTUNITIES 50

    5.3.3.1 Emerging countries to present high-growth opportunities 50

    5.3.3.2 3D cell expansion technology: A new opportunity 50

    5.3.4 CHALLENGE 51

    5.3.4.1 Survival of small players and new entrants 51

    6 CELL EXPANSION MARKET, BY PRODUCT 52

    6.1 INTRODUCTION 53

    6.2 CONSUMABLES 54

    6.2.1 REAGENTS, MEDIA, AND SERUM 56

    6.2.2 DISPOSABLES 57

    6.2.2.1 Tissue culture flasks 58

    6.2.2.2 Bioreactor accessories 59

    6.2.2.3 Other disposables 60

    6.3 INSTRUMENTS 61

    6.3.1 CELL EXPANSION SUPPORTING EQUIPMENT 63

    6.3.1.1 Flow cytometers 64

    6.3.1.2 Centrifuges 65

    6.3.1.3 Cell counters 66

    6.3.1.4 Other supporting equipment 67

    6.3.2 BIOREACTORS 67

    6.3.2.1 Microcarrier bioreactors 69

    6.3.2.1.1 Microcarrier-based anchorage-dependent bioreactors 70

    6.3.2.1.2 Suspension-based anchorage independent bioreactors 71

    6.3.2.2 Perfusion/hollow fiber bioreactors 71

    6.3.3 AUTOMATED CELL EXPANSION SYSTEMS 72

    7 CELL EXPANSION MARKET, BY CELL TYPE 74

    7.1 INTRODUCTION 75

    7.2 HUMAN CELLS 76

    7.2.1 STEM CELLS 77

    7.2.1.1 Adult stem cells 79

    7.2.1.2 Induced pluripotent stem cells 81

    7.2.1.3 Embryonic stem cells 82

    7.2.2 DIFFERENTIATED CELLS 83

    7.3 ANIMAL CELLS 84

    8 CELL EXPANSION MARKET, BY APPLICATION 85

    8.1 INTRODUCTION 86

    8.2 REGENERATIVE MEDICINE AND STEM CELL RESEARCH 87

    8.3 CANCER AND CELL-BASED RESEARCH 88

    8.4 OTHERS 89

    9 CELL EXPANSION MARKET, BY END USER 90

    9.1 INTRODUCTION 91

    9.2 RESEARCH INSTITUTES 92

    9.3 BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 93

    9.4 CELL BANKS 94

    9.5 OTHERS 95

    10 CELL EXPANSION MARKET, BY REGION 96

    10.1 INTRODUCTION 97

    10.2 NORTH AMERICA 99

    10.2.1 U.S. 105

    10.2.2 CANADA 107

    10.3 EUROPE 109

    10.3.1 GERMANY 116

    10.3.2 U.K. 117

    10.3.3 FRANCE 119

    10.3.4 ITALY 121

    10.3.5 SPAIN 122

    10.3.6 REST OF EUROPE 124

    10.4 ASIA 126

    10.4.1 JAPAN 133

    10.4.2 CHINA 135

    10.4.3 INDIA 136

    10.4.4 REST OF ASIA 138

    10.5 REST OF THE WORLD 140

    11 COMPETITIVE LANDSCAPE 145

    11.1 OVERVIEW 145

    11.2 MARKET SHARE ANALYSIS 146

    11.3 COMPETITIVE SITUATION AND TRENDS 147

    11.3.1 NEW PRODUCT LAUNCHES 148

    11.3.2 AGREEMENTS AND COLLABORATIONS 149

    11.3.3 EXPANSIONS 150

    11.3.4 ACQUISITIONS 151

    11.3.5 OTHER DEVELOPMENTS 152

    12 COMPANY PROFILES 153

    (Business Overview, Products, Company Snapshot, Recent Developments, MnM View)*

    12.1 INTRODUCTION 153

    12.2 THERMO FISHER SCIENTIFIC, INC. 154

    12.3 GE HEALTHCARE (A WHOLLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 158

    12.4 LONZA GROUP LTD. 161

    12.5 BECTON, DICKINSON AND COMPANY 164

    12.6 CORNING, INC. 167

    12.7 MERCK KGAA 170

    12.8 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION) 173

    12.9 MILTENYI BIOTEC 175

    12.10 STEMCELL TECHNOLOGIES 177

    12.11 TERUMO BCT, INC. (A SUBSIDIARY OF TERUMO CORPORATION) 179

    *Details on company financial might not be captured in case of unlisted companies

    13 APPENDIX 181

    13.1 INSIGHTS OF INDUSTRY EXPERTS 181

    13.2 DISCUSSION GUIDE 182

    13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 186

    13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 188

    13.5 AVAILABLE CUSTOMIZATIONS 188

    13.6 RELATED REPORTS 189

List Of Tables
in Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021

LIST OF TABLES


TABLE 1 RISING INCIDENCES OF CANCER, BY TYPE (IN THOUSANDS) 45

TABLE 2 NATIONAL INSTITUTES OF HEALTH (NIH) FUNDING IN THE U.S.,

2013-2016 (USD MILLION) 46

TABLE 3 R&D EXPENDITURE OF BIOTECHNOLOGY FIRMS, BY COUNTRY 47

TABLE 4 CELLULAR AND GENE THERAPY MARKETED PRODUCTS APPROVED BY FDA 47

TABLE 5 RISING REGULATORY APPROVALS FOR GOOD MANUFACTURING PRACTICES TO BOOST THE MARKET 48

TABLE 6 INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING GOVERNMENT INVESTMENTS ARE DRIVING THE CELL EXPANSION MARKET 48

TABLE 7 HIGH COST OF CELL-BASED RESEARCH IS EXPECTED TO RESTRAIN MARKET GROWTH 49

TABLE 8 ASIAN ECONOMIES TO CREATE NEW GROWTH OPPORTUNITIES IN THE MARKET 50

TABLE 9 SURVIVAL OF SMALL PLAYERS AND NEW ENTRANTS IS A MAJOR CHALLENGE IN THE CELL EXPANSION MARKET 51

TABLE 10 CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 54

TABLE 11 CONSUMABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 54

TABLE 12 NORTH AMERICA: CONSUMABLES MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 55

TABLE 13 EUROPE: CONSUMABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 55

TABLE 14 ASIA: CONSUMABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 55

TABLE 15 CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 56

TABLE 16 REAGENTS, MEDIA, AND SERUM MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 56

TABLE 17 DISPOSABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 57

TABLE 18 DISPOSABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 58

TABLE 19 TISSUE CULTURE FLASKS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 58

TABLE 20 BIOREACTOR ACCESSORIES MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 59

TABLE 21 OTHER DISPOSABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 60

TABLE 22 INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 61

TABLE 23 NORTH AMERICA: INSTRUMENTS MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 62

TABLE 24 EUROPE: INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 62

TABLE 25 ASIA: INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 62

TABLE 26 INSTRUMENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 63

TABLE 27 CELL EXPANSION SUPPORTING EQUIPMENT MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 63

TABLE 28 CELL EXPANSION SUPPORTING EQUIPMENT MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 64

TABLE 29 FLOW CYTOMETER MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 65

TABLE 30 CENTRIFUGE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 65

TABLE 31 CELL COUNTERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 66

TABLE 32 OTHER SUPPORTING EQUIPMENT MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 67

TABLE 33 BIOREACTOR MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 68

TABLE 34 BIOREACTOR MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 69

TABLE 35 MICROCARRIER BIOREACTORS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 69

TABLE 36 MICROCARRIER BIOREACTOR MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 70

TABLE 37 MICROCARRIER-BASED ANCHORAGE-DEPENDENT BIOREACTOR MARKET SIZE,

BY REGION, 2014–2021 (USD MILLION) 70

TABLE 38 SUSPENSION-BASED ANCHORAGE INDEPENDENT BIOREACTOR MARKET SIZE,

BY REGION, 2014–2021 (USD MILLION) 71

TABLE 39 PERFUSION/HOLLOW FIBER BIOREACTORS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 72

TABLE 40 AUTOMATED CELL EXPANSION SYSTEM MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 73

TABLE 41 CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 75

TABLE 42 HUMAN CELLS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 76

TABLE 43 HUMAN CELLS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 77

TABLE 44 STEM CELLS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 78

TABLE 45 STEM CELLS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 79

TABLE 46 GOVERNMENT INVESTMENTS FOR ENHANCING STEM CELL RESEARCH,

2013-2015 80

TABLE 47 ADULT STEM CELLS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 80

TABLE 48 RISING INCIDENCE OF DISEASES TO TRIGGER MARKET GROWTH 81

TABLE 49 INDUCED PLURIPOTENT STEM CELLS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 82

TABLE 50 EMBRYONIC STEM CELLS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 82

TABLE 51 DIFFERENTIATED CELLS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 83

TABLE 52 ANIMAL CELLS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 84

TABLE 53 CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 87

TABLE 54 REGENERATIVE MEDICINES AND STEM CELL RESEARCH MARKET SIZE,

BY REGION, 2014–2021 (USD MILLION) 87

TABLE 55 CANCER AND CELL-BASED RESEARCH MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 89

TABLE 56 OTHERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 89

TABLE 57 CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 92

TABLE 58 RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 92

TABLE 59 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES MARKET SIZE,

BY REGION, 2014–2021 (USD MILLION) 94

TABLE 60 CELL BANKS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 94

TABLE 61 OTHERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 95

TABLE 62 WORLDWIDE NUMBER OF DEATHS, BY DISEASE, 2008–2030 (IN THOUSANDS) 97

TABLE 63 CELL EXPANSION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 98

TABLE 64 NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 101

TABLE 65 NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 101

TABLE 66 NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR CONSUMABLES,

BY TYPE, 2014–2021 (USD MILLION) 101

TABLE 67 NORTH AMERICA: CELL EXPANSION CONSUMABLES MARKET SIZE FOR DISPOSABLES, BY TYPE, 2014–2021 (USD MILLION) 102

TABLE 68 NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR INSTRUMENTS,

BY TYPE, 2014–2021 (USD MILLION) 102

TABLE 69 NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR SUPPORTING EQUIPMENT, BY TYPE, 2014–2021 (USD MILLION) 102

TABLE 70 NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR BIOREACTORS,

BY TYPE, 2014–2021 (USD MILLION) 103

TABLE 71 NORTH AMERICA: CELL EXPANSION BIOREACTORS MARKET SIZE FOR MICROCARRIER BIOREACTORS, BY TYPE, 2014–2021 (USD MILLION) 103

TABLE 72 NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY CELL TYPE,

2014–2021 (USD MILLION) 103

TABLE 73 NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR HUMAN CELLS,

BY CELL TYPE, 2014–2021 (USD MILLION) 104

TABLE 74 NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR STEM CELLS,

BY CELL TYPE, 2014–2021 (USD MILLION) 104

TABLE 75 NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 104

TABLE 76 NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 105

TABLE 77 U.S.: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 106

TABLE 78 U.S.: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 106

TABLE 79 U.S.: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 106

TABLE 80 U.S.: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 107

TABLE 81 CANADA: CELL EXPANSION MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 107

TABLE 82 CANADA: CELL EXPANSION MARKET SIZE, BY CELL TYPE,

2014–2021 (USD MILLION) 108

TABLE 83 CANADA: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 108

TABLE 84 CANADA: CELL EXPANSION MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 108

TABLE 85 EUROPE: CELL EXPANSION MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 111

TABLE 86 EUROPE: CELL EXPANSION MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 112

TABLE 87 EUROPE: CELL EXPANSION MARKET SIZE FOR CONSUMABLES, BY TYPE,

2014–2021 (USD MILLION) 112

TABLE 88 EUROPE: CELL EXPANSION CONSUMABLES MARKET SIZE FOR DISPOSABLES,

BY TYPE, 2014–2021 (USD MILLION) 112

TABLE 89 EUROPE: CELL EXPANSION MARKET SIZE FOR INSTRUMENTS, BY TYPE,

2014–2021 (USD MILLION) 113

TABLE 90 EUROPE: CELL EXPANSION MARKET SIZE FOR SUPPORTING EQUIPMENT,

BY TYPE, 2014–2021 (USD MILLION) 113

TABLE 91 EUROPE: CELL EXPANSION MARKET SIZE FOR BIOREACTORS, BY TYPE,

2014–2021 (USD MILLION) 113

TABLE 92 EUROPE: CELL EXPANSION BIOREACTORS MARKET SIZE FOR MICROCARRIER BIOREACTORS, BY TYPE, 2014–2021 (USD MILLION) 114

TABLE 93 EUROPE: CELL EXPANSION MARKET SIZE, BY CELL TYPE,

2014–2021 (USD MILLION) 114

TABLE 94 EUROPE: CELL EXPANSION MARKET SIZE FOR HUMAN CELLS,

BY CELL TYPE, 2014–2021 (USD MILLION) 114

TABLE 95 EUROPE: CELL EXPANSION MARKET SIZE FOR STEM CELLS, BY CELL TYPE,

2014–2021 (USD MILLION) 115

TABLE 96 EUROPE: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 115

TABLE 97 EUROPE: CELL EXPANSION MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 115

TABLE 98 GERMANY: CELL EXPANSION MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 116

TABLE 99 GERMANY: CELL EXPANSION MARKET SIZE, BY CELL TYPE,

2014–2021 (USD MILLION) 116

TABLE 100 GERMANY: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 117

TABLE 101 GERMANY: CELL EXPANSION MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 117

TABLE 102 U.K.: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 118

TABLE 103 U.K.: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 118

TABLE 104 U.K.: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 118

TABLE 105 U.K.: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 119

TABLE 106 FRANCE: CELL EXPANSION MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 119

TABLE 107 FRANCE: CELL EXPANSION MARKET SIZE, BY CELL TYPE,

2014–2021 (USD MILLION) 120

TABLE 108 FRANCE: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 120

TABLE 109 FRANCE: CELL EXPANSION MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 120

TABLE 110 ITALY: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 121

TABLE 111 ITALY: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 121

TABLE 112 ITALY: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 122

TABLE 113 ITALY: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 122

TABLE 114 SPAIN: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 123

TABLE 115 SPAIN: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 123

TABLE 116 SPAIN: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 123

TABLE 117 SPAIN: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 124

TABLE 118 ROE: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 124

TABLE 119 ROE: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 125

TABLE 120 ROE: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 125

TABLE 121 ROE: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 125

TABLE 122 ASIA: CELL EXPANSION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 128

TABLE 123 ASIA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 129

TABLE 124 ASIA: CELL EXPANSION MARKET SIZE FOR CONSUMABLES, BY TYPE,

2014–2021 (USD MILLION) 129

TABLE 125 ASIA: CELL EXPANSION CONSUMABLES MARKET SIZE FOR DISPOSABLES,

BY TYPE, 2014–2021 (USD MILLION) 129

TABLE 126 ASIA: CELL EXPANSION MARKET SIZE FOR INSTRUMENTS, BY TYPE,

2014–2021 (USD MILLION) 130

TABLE 127 ASIA: CELL EXPANSION MARKET SIZE FOR SUPPORTING EQUIPMENT,

BY TYPE, 2014–2021 (USD MILLION) 130

TABLE 128 ASIA: CELL EXPANSION MARKET SIZE FOR BIOREACTORS, BY TYPE,

2014–2021 (USD MILLION) 130

TABLE 129 ASIA: CELL EXPANSION BIOREACTORS MARKET SIZE FOR MICROCARRIER BIOREACTORS, BY TYPE, 2014–2021 (USD MILLION) 131

TABLE 130 ASIA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 131

TABLE 131 ASIA: CELL EXPANSION MARKET SIZE FOR HUMAN CELLS, BY CELL TYPE,

2014–2021 (USD MILLION) 131

TABLE 132 ASIA: CELL EXPANSION MARKET SIZE FOR STEM CELLS, BY CELL TYPE,

2014–2021 (USD MILLION) 132

TABLE 133 ASIA: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 132

TABLE 134 ASIA: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 132

TABLE 135 INVESTMENTS IN MEDICAL RESEARCH PROJECTS, 2014 133

TABLE 136 JAPAN: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 133

TABLE 137 JAPAN: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 134

TABLE 138 JAPAN: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 134

TABLE 139 JAPAN: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 134

TABLE 140 CHINA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 135

TABLE 141 CHINA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 135

TABLE 142 CHINA: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 136

TABLE 143 CHINA: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 136

TABLE 144 INDIA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 137

TABLE 145 INDIA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 137

TABLE 146 INDIA: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 137

TABLE 147 INDIA: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 138

TABLE 148 ROA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 138

TABLE 149 ROA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 138

TABLE 150 ROA: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 139

TABLE 151 ROA: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 139

TABLE 152 ROW: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 140

TABLE 153 ROW: CELL EXPANSION MARKET SIZE FOR CONSUMABLES, BY TYPE,

2014–2021 (USD MILLION) 140

TABLE 154 ROW: CELL EXPANSION CONSUMABLES MARKET SIZE FOR DISPOSABLES,

BY TYPE, 2014–2021 (USD MILLION) 141

TABLE 155 ROW: CELL EXPANSION MARKET SIZE FOR INSTRUMENTS, BY TYPE,

2014–2021 (USD MILLION) 141

TABLE 156 ROW: CELL EXPANSION MARKET SIZE FOR SUPPORTING EQUIPMENT,

BY TYPE, 2014–2021 (USD MILLION) 141

TABLE 157 ROW: CELL EXPANSION MARKET SIZE FOR BIOREACTORS, BY TYPE,

2014–2021 (USD MILLION) 142

TABLE 158 ROW: CELL EXPANSION BIOREACTORS MARKET SIZE FOR MICROCARRIER BIOREACTORS, BY TYPE, 2014–2021 (USD MILLION) 142

TABLE 159 ROW: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014–2021 (USD MILLION) 142

TABLE 160 ROW: CELL EXPANSION MARKET SIZE FOR HUMAN CELLS, BY CELL TYPE,

2014–2021 (USD MILLION) 143

TABLE 161 ROW: CELL EXPANSION MARKET SIZE FOR STEM CELLS, BY CELL TYPE,

2014–2021 (USD MILLION) 143

TABLE 162 ROW: CELL EXPANSION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 143

TABLE 163 ROW: CELL EXPANSION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 144

TABLE 164 NEW PRODUCT LAUNCHES, 2013-2016 148

TABLE 165 AGREEMENTS AND COLLABORATIONS, 2013-2016 149

TABLE 166 EXPANSIONS, 2013-2016 150

TABLE 167 ACQUISITIONS, 2013-2016 151

TABLE 168 OTHER DEVELOPMENTS, 2013-2016 152

List Of Figures, Charts and Diagrams
in Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021

LIST OF FIGURES


FIGURE 1 CELL EXPANSION MARKET SEGMENTATION 19

FIGURE 2 RESEARCH DESIGN 21

FIGURE 3 TOP-DOWN APPROACH 23

FIGURE 4 BOTTOM-UP APPROACH 23

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 24

FIGURE 6 DATA TRIANGULATION METHODOLOGY 25

FIGURE 1 CELL EXPANSION MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION) 30

FIGURE 2 CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2016 VS. 2021 (USD MILLION) 31

FIGURE 3 CELL EXPANSION MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION) 31

FIGURE 4 CELL EXPANSION MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION) 32

FIGURE 5 CELL EXPANSION MARKET, BY REGION, 2016 (USD MILLION) 33

FIGURE 6 CELL EXPANSION MARKET TO SHOWCASE HIGH GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 35

FIGURE 7 CONSUMABLES SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 36

FIGURE 8 HUMAN CELLS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 37

FIGURE 9 REGENERATIVE MEDICINE AND STEM CELL RESEARCH APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016 38

FIGURE 10 U.S. TO DOMINATE THE CELL EXPANSION MARKET IN 2016 39

FIGURE 11 ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE CELL EXPANSION MARKET DURING THE FORECAST PERIOD 40

FIGURE 12 CELL EXPANSION MARKET SEGMENTATION 43

FIGURE 13 CELL EXPANSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44

FIGURE 14 GLOBAL PREVALENCE OF DIABETES, BY REGION (IN MILLION) 45

FIGURE 15 CONSUMABLES SEGMENT IS EXPECTED TO DOMINATE THE CELL EXPANSION PRODUCTS MARKET DURING THE FORECAST PERIOD 53

FIGURE 16 TISSUE CULTURE FLASK TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 57

FIGURE 17 CELL EXPANSION SUPPORTING EQUIPMENT IS EXPECTED TO GROW AT HIGHEST CAGR DURING THE FORECAST PERIOD 61

FIGURE 18 ASIA TO GROW AT THE HIGHEST CAGR IN THE BIOREACTOR MARKET DURING THE FORECAST PERIOD 68

FIGURE 19 HUMAN CELLS SEGMENT EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 75

FIGURE 20 ADULT STEM CELLS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 78

FIGURE 21 REGENERATIVE MEDICINE AND STEM CELL RESEARCH EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 86

FIGURE 22 ASIA IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 88

FIGURE 23 RESEARCH INSTITUTES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016 91

FIGURE 24 ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT DURING THE FORECAST PERIOD 93

FIGURE 25 GEOGRAPHIC SNAPSHOT: EMERGING MARKETS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 98

FIGURE 26 NORTH AMERICA: CELL EXPANSION MARKET SNAPSHOT 100

FIGURE 27 EUROPE: CELL EXPANSION MARKET SNAPSHOT 110

FIGURE 28 EUROPE: ESTIMATED NUMBER OF NEW CANCER CASES, 2012–2020 (IN THOUSANDS) 111

FIGURE 29 ASIA: CELL EXPANSION MARKET SNAPSHOT 127

FIGURE 30 ASIA: AN ATTRACTIVE MARKET FOR CELL EXPANSION 128

FIGURE 31 NEW PRODUCT LAUNCH IS THE KEY GROWTH STRATEGY FOR MARKET PLAYERS FROM 2013 TO 2016 145

FIGURE 32 GLOBAL CELL EXPANSION MARKET SHARE, BY KEY PLAYER, 2015 146

FIGURE 33 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCH IS THE PREFERRED STRATEGY FOR MARKET PLAYERS 147

FIGURE 34 PRODUCT BENCHMARKING FOR TOP 6 MARKET PLAYERS 153

FIGURE 35 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 154

FIGURE 36 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT 158

FIGURE 37 LONZA GROUP LTD.: COMPANY SNAPSHOT 161

FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 164

FIGURE 39 CORNING, INC.: COMPANY SNAPSHOT 167

FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT 170

FIGURE 41 DANAHER CORPORATION: COMPANY SNAPSHOT 173

FIGURE 42 TERUMO CORPORATION: COMPANY SNAPSHOT 179

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

51130 | BT 2850

Number of Pages

188

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Head and Neck Squamous Cell Carcinoma: KOL Insight
IntroductionImmunotherapies are about to transform HNSCC treatment. Can one brand corner the market?...
01 Mar 2016 by FirstWord Pharma USD $7,900 More Info
NPS+ Renal Cell Carcinoma (US)
IntroductionTwo brands lead the RCC treatment market. How does your brand stack up?US oncologists ma...
01 Feb 2016 by FirstWord Pharma USD $2,495 More Info
NPS+ Renal Cell Carcinoma (EU5)
IntroductionCompare 8 major RCC brands. Learn which one scores 6 times higher than any other?FirstVi...
01 Feb 2016 by FirstWord Pharma USD $2,495 More Info
Non-Small Cell Lung Cancer: Update Bulletin [Jan 2016]
IntroductionGain new KOL insights on the latest events that have the potential to shape the targeted...
01 Jan 2016 by FirstWord Pharma USD $995 More Info
Non-Small Cell Lung Cancer: KOL Insight
IntroductionNon-Small Cell Lung Cancer: KOL Insight offers detailed expert opinion on the continuing...
01 Jul 2015 by FirstWord Pharma USD $7,900 More Info
Physician Views – Taking a post-ASCO pulse on the PD-L1 biomarker debate in non-small-cell lung cancer
ScopeThe data presented at this year's ASCO annual meeting, which has subsequently fuelled the most ...
01 Jun 2015 by FirstWord Pharma USD $695 More Info
Physician Views: Oncologist expectations for immunotherapy in first-line non-small-cell lung cancer
ScopeMuch of the debate around cancer immunotherapy at the recent ASCO annual meeting focused on the...
01 Jun 2015 by FirstWord Pharma USD $695 More Info
Physician Views: Will an Opdivo/Yervoy combination succeed in melanoma and can Keytruda keep pace in non-small-cell lung cancer?
Scope New data presented at the annual meeting of the American Association for Cancer Research (AACR...
23 Apr 2015 by FirstWord Pharma USD $695 More Info
Renal Cell Carcinoma: KOL Insight
IntroductionWill new checkpoint inhibitors revive immunotherapy in RCC?Renal Cell Carcinoma: KOL Ins...
01 Feb 2015 by FirstWord Pharma USD $7,900 More Info
Physician Views: Reaction to Bristol-Myers Squibb's Opdivo data in non-small-cell lung cancer
Scope Studies of Bristol-Myers Squibb's PD-1 inhibitor nivolumab in non-small-cell lung cancer (NSCL...
06 Nov 2014 by FirstWord Pharma USD $695 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...